Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21 Waf1/Cip1

Oncogene

Volumn 29, Issue 15, 2010, Pages 2262-2271

  Borgdorff, V ^a,c   Lleonart, M E ^b   Bishop, C L ^a   Fessart, D ^a   Bergin, A H ^a   Overhoff, M G ^a   Beach, D H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

MiRNA; Oncogene induced senescence; P21Waf1 Cip1; Ras; SiRNA

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MICRORNA; RAS PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BREAST EPITHELIUM; CANCER INHIBITION; CELL AGING; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL AGING; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAMMARY GLANDS, HUMAN; MICRORNAS; RAS PROTEINS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 77951054607     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.497     Document Type: Article

References (24)

1. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM. (2000). Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19: 5338-5347.
2. Braig M, Schmitt CA. (2006). Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66: 2881-2884.
3. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
4. Carbone CJ, Grana X, Reddy EP, Haines DS. (2007). p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-trans-duced primary mouse fibroblasts. Cancer Res 67: 4130-4137.
5. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024-7029.
6. Courtois-Cox S, Jones SL, Cichowski K. (2008). Many roads lead to oncogene-induced senescence. Oncogene 27: 2801-2809.
7. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL et al. (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65.
8. Gohring UJ, Bersch A, Becker M, Neuhaus W, Schondorf T. (2001). p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer. J Clin Pathol 54: 866-870.
9. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
10. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
11. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
12. Li G, Luna C, Qiu J, Epstein DL. (2009). Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev 130: 731-741.
13. Li Y, Pan J, Li JL, Lee JH, Tunkey C, Saraf K et al. (2007). Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol Cancer 6: 7
14. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
15. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. (2007). Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9: 493-505.
16. INK4a. Cell 88: 593-602.
17. Sherr CJ, McCormick F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2: 103-112.
18. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
19. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY et al. (2004). Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498.
20. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
21. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40: 1478-1483.
22. Wei W, Jobling WA, Chen W, Hahn WC, Sedivy JM. (2003). Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induction anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol Cell Biol 23: 2859-2870.
23. Weiss RH. (2003). p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4: 425-429.
24. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592.